Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Stephen Mahoney appointed President and Chief Executive Officer – – Potential best-in-class subcutaneous and intravenous thyroid eye disease programs targeting insulin-like growth factor 1...
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) hit a new 52-week low during mid-day trading on Friday after UBS Group lowered their price target on the stock from $83.00 to $39.00. UBS Group currently has a buy rating on the stock. Akero Therapeutics traded as low as $14.03 and last traded at $14.05, with […]
SAB also announces closing of $7.5 million financing, the first tranche of $130 million private placementSIOUX FALLS, S.D., Oct. 05, 2023 -- SAB Biotherapeutics ; class='js-l-obf link...
Vistagen Therapeutics, Inc. , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous...
SAB Biotherapeutics (NASDAQ: SABS) has entered into a securities purchase agreement with certain investors to issue and sell shares of preferred stock in a private placement of up to $130 million in gross proceeds.